Phathom Pharmaceuticals Reports Officer and Director Changes
Ticker: PHAT · Form: 8-K · Filed: Oct 6, 2025 · CIK: 1783183
| Field | Detail |
|---|---|
| Company | Phathom Pharmaceuticals, Inc. (PHAT) |
| Form Type | 8-K |
| Filed Date | Oct 6, 2025 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.0001, $550,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, corporate-governance
TL;DR
Phathom Pharma's board and execs are changing, effective Oct 2nd.
AI Summary
Phathom Pharmaceuticals, Inc. filed an 8-K on October 6, 2025, reporting changes effective October 2, 2025. The filing pertains to the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. Specific details regarding these changes and arrangements are outlined within the document.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus.
Risk Assessment
Risk Level: medium — Changes in key leadership roles can indicate underlying issues or strategic shifts that may impact the company's future performance.
Key Players & Entities
- Phathom Pharmaceuticals, Inc. (company) — Registrant
- October 2, 2025 (date) — Effective date of reported changes
- October 6, 2025 (date) — Filing date of the 8-K
FAQ
What specific roles have seen departures or appointments?
The filing indicates changes related to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers,' but the specific names and roles are not detailed in the provided text.
When were these changes officially effective?
The earliest event reported, and thus the effective date of the changes, was October 2, 2025.
What is the primary purpose of this 8-K filing?
This 8-K filing serves as a current report to the SEC to disclose significant events, specifically changes in the company's directors and officers, and related compensation arrangements.
Where is Phathom Pharmaceuticals, Inc. headquartered?
Phathom Pharmaceuticals, Inc. is headquartered at 100 Campus Drive, Suite 102, Florham Park, New Jersey 07932.
What is the Standard Industrial Classification (SIC) code for Phathom Pharmaceuticals?
The SIC code for Phathom Pharmaceuticals is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 1,443 words · 6 min read · ~5 pages · Grade level 11.9 · Accepted 2025-10-06 08:05:23
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share PHAT The Nasdaq Global Se
- $550,000 — la's initial annual base salary will be $550,000 and he will be eligible for an annual t
Filing Documents
- d76139d8k.htm (8-K) — 29KB
- 0001193125-25-230984.txt ( ) — 143KB
- phat-20251002.xsd (EX-101.SCH) — 3KB
- phat-20251002_lab.xml (EX-101.LAB) — 18KB
- phat-20251002_pre.xml (EX-101.PRE) — 11KB
- d76139d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PHATHOM PHARMACEUTICALS, INC. Date: October 6, 2025 By: /s/ Anne Marie Cook Anne Marie Cook Chief Legal Officer